BD1925649
(1R,3R)-Methyl1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate , 98% , 171596-41-1
CAS NO.:171596-41-1
Empirical Formula: C20H18N2O4
Molecular Weight: 350.37
MDL number: MFCD04973634
EINECS: 1312995-182-4
| Pack Size | Price | Stock | Quantity |
| 1g | RMB9396.80 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 83-85°C |
| Boiling point: | 531.0±50.0 °C(Predicted) |
| Density | 1.359±0.06 g/cm3(Predicted) |
| storage temp. | Refrigerator |
| solubility | Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) |
| form | Solid |
| pka | 16.87±0.60(Predicted) |
| color | White to Off-White |
| InChI | InChI=1S/C20H18N2O4/c1-24-20(23)15-9-13-12-4-2-3-5-14(12)21-19(13)18(22-15)11-6-7-16-17(8-11)26-10-25-16/h2-8,15,18,21-22H,9-10H2,1H3/t15-,18-/m1/s1 |
| InChIKey | LIPVUDSNGRJSQE-CRAIPNDOSA-N |
| SMILES | N1C2=C(C=CC=C2)C2C[C@H](C(OC)=O)N[C@H](C3=CC=C4OCOC4=C3)C1=2 |
Description and Uses
(1R,3R)-Methyl-1,2,3,4-tetrahydro-1-(3,4-Methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate can be used as an intermediate in the synthesis of Tadafil, which is used for the treatment of erectile dysfunction.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319 |
| Precautionary statements | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 |

![(1R,3R)-Methyl1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate](https://img.chemicalbook.com/CAS/GIF/171596-41-1.gif)

![(1R,3R)-Methyl1-(benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate](https://img.chemicalbook.com/CAS/GIF/171489-59-1.gif)
![(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride](https://img.chemicalbook.com/CAS/GIF/171752-68-4.gif)